中文|English
Navigation
Company introduction

China Grand Enterprises, Inc. (hereinafter referred to as CGE), established in 1993, is a joint-stock group company, headquartered in Grand Place, Beijing Asian Games Village. As an investment company engaged in operation and management, CGE’s core businesses cover pharmaceuticals and healthcare, property investment, commercial trade business, financial services and other industries.

 

1. Pharmaceuticals and Healthcare Industry

In the field of pharmaceuticals and healthcare industry, CGE has established several core industrial platforms within her controlled subsidiary companies. These include Huadong Pharmaceutical Co., Ltd. that plays a leading role in fermentation-based pharmaceutical production, Grand Pharma (China) Co., Ltd. a leader in synthetic chemistry-based pharmaceutical production, Lei Yunshang Pharmaceutical Group with a nearly 300-year history operating in the production of modern Traditional Chinese Medicine, and Grand Shuyang Pharmaceutical Co., Ltd. focusing on the production of blood products, vaccines and other biopharmaceutical products.  CGE pharmaceutical and healthcare industry produces nearly a thousand pharmaceutical products which belong to three major categories including synthetic chemical drugs, traditional Chinese medicines and biopharmaceuticals consisting mainly of blood products and vaccines. Among the products of CGE pharmaceutical and healthcare industry are included various bulk active pharmaceutical ingredients (APIs), steroid hormones, adrenalines and a variety of specialty APIs, fine chemicals and chemical intermediates, healthcare products and various other classes of 

copyright ©2015 Jiangsu broad economic development co., LTD

Home | Contact us | Business | About us |